CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 95 enrolled
Drug / intervention
Pure-Vu Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03503162
NCT03503162N/ACompleted
CompareCT.gov

Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

Motus GI Medical Technologies Ltd·interventional·Posted Apr 19, 2018·Updated Apr 13, 2021

In Brief

A clinical study evaluating Pure-Vu System for Gastrointestinal Disease and Colorectal Cancer. Completed, enrolled 95 participants across 1 site.

Detailed Summary

The aim of this study is to evaluate the potential improvement in colonoscopy procedure's outcomes when using the Pure-Vu System in hospitalized patients who are indicated for colonoscopy procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Disease, Colorectal Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 19, 2018
Enrollment StartMay 17, 2018
Primary CompletionMay 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.2 years ago

Interventions

Pure-Vu Systemdevice

The Pure-Vu System is FDA cleared device and CE marking received in February 2018, intended to connect to standard colonoscopes to help facilitate intra-procedural cleaning of a poorly prepared colon by irrigating or cleaning the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter, e.g. blood.